Simavita logo

SV - Simavita Share Price

C$0.05 0.0  0.0%

Last Trade - 13/07/16

Sector
Healthcare
Size
Micro Cap
Market Cap £5.66m
Enterprise Value £7.72m
Revenue £25.0k
Position in Universe th / 2682
Bullish
Bearish
Unlock SV Revenue
Momentum
Relative Strength (%)
1m +34.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.78 0.87 0.93 0.42 0.19 0.045 -43.4%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 30 June 2020, Simavita Ltdrevenues decreased 76% to A$45K. Net loss increased 3% toA$4.1M. Revenues reflect Revenue decrease of 76% to A$43K,Interest revenue decrease of 59% to A$2K. Higher net lossreflects Research and development increase of 51% to A$1.7M(expense), General and administration increase of 23% toA$2.3M (expense), Finance costs increase from A$225K toA$518K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

SV Revenue Unlock SV Revenue

Net Income

SV Net Income Unlock SV Revenue

Normalised EPS

SV Normalised EPS Unlock SV Revenue

PE Ratio Range

SV PE Ratio Range Unlock SV Revenue

Dividend Yield Range

SV Dividend Yield Range Unlock SV Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
SV EPS Forecasts Unlock SV Revenue
Profile Summary

Simavita Limited focuses on the sale and distribution of a range of products derived from its incontinence assessment and management technology, Smart Incontinence Management (SIM), with an emphasis on the United States, European marketplaces and Australia. The Company offers various products, which include SIM sensor, SIM pod, SIM assist application, SIM Wireless Fidelity enabling devices. The SIM pod is a wearable medical device, which connects to the SIM sensor and wirelessly transmits incontinence data to a server. The incontinence data collected is synchronized and processed with the incontinence-related observations, which are recorded through the SIM assist application. The SIM sensor is a single-use disposable device, which detects and records incontinence data. The SIM assist application is a software application, which allows caregivers to take observations and integrate them directly into the incontinence assessment record using the mobile technology.

Directors
Last Annual June 30th, 2020
Last Interim June 30th, 2020
Incorporated November 27, 2013
Public Since February 20, 2014
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange TSX Venture Exchange
Shares in Issue 671,591,065
Free Float (0.0%)
Eligible for
ISAs
SIPPs
SV Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for SV
Upcoming Events for SV
Frequently Asked Questions for Simavita
What is the Simavita share price?

As of 13/07/16, shares in Simavita are trading at C$0.05, giving the company a market capitalisation of £5.66m. This share price information is delayed by 15 minutes.

How has the Simavita share price performed this year?

Shares in Simavita are currently trading at C$0.05 and the price has moved by -90.2% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Simavita price has moved by -90.23% over the past year.

What are the analyst and broker recommendations for Simavita?

There are no analysts currently covering Simavita.

When will Simavita next release its financial results?

Simavita is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Simavita dividend yield?

Simavita does not currently pay a dividend.

Does Simavita pay a dividend?

Simavita does not currently pay a dividend.

When does Simavita next pay dividends?

Simavita does not currently pay a dividend.

How do I buy Simavita shares?

To buy shares in Simavita you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Simavita?

Shares in Simavita are currently trading at C$0.05, giving the company a market capitalisation of £5.66m.

Where are Simavita shares listed? Where are Simavita shares listed?

Here are the trading details for Simavita:

Country of listing: Canada
Exchange: CVE
Ticker Symbol: SV
What kind of share is Simavita?

We were not able to load our ranking data for Simavita

Is there a Simavita share price forecast 2020?

We were not able to load any forecast data for Simavita.

How can I tell whether the Simavita share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Simavita. Over the past six months, the relative strength of its shares against the market has been -79.8%. At the current price of C$0.05, shares in Simavita are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Simavita PE Ratio?

We were not able to find PE ratio data for Simavita.

Who are the key directors of Simavita?

Simavita's management team is headed by:

Damien Haakman - DRC
Peta Jurd - SEC
Michael Spooner - CHM
Gary Pace - NED
Alan Fisher - DRC
John McBain - DRC
Who are the major shareholders of Simavita?

Here are the top five shareholders of Simavita based on the size of their shareholding:

Similar to SV
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.